🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Detection

CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites📍 Tucson📍 Aurora📍 Washington D.C. Personalis Inc. Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site📍 Buenos Aires Oncoliq US Inc · Tests: Peripheral blood draw Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer NCT06876610n/a1 site📍 Beijing Geneplus-Beijing Co. Ltd. UCF MammoChat: Image Repository NCT07214883n/a1 site📍 Orlando University of Central Florida · Tests: No Interventions A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer NCT04985266Phase 249 sites📍 Angers📍 Annecy📍 Avignon Royal Marsden NHS Foundation Trust · Tests: Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer NCT07003009NA1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: Malign Lymph Node Washout, Benign Lymph Node Washout A Study to Identify Breast Cancer (IDBC) NCT04495244n/a4 sites📍 Calgary📍 Soeul📍 Manchester Syantra Inc. · Tests: Syantra DX Breast Cancer Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer NCT06540872Phase 22 sites📍 Essen📍 Münster Universität Münster · Tests: [68Ga]Ga-FAPI-46 IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases NCT06092892Phase 23 sites📍 Los Angeles📍 Pasadena📍 Tarzana Alice Chung · Tests: Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant Radiation Therapy Evaluation of the Bexa Breast Examination NCT06643767NA1 site📍 Abilene Sure, Inc. · Tests: Bexa and focus ultrasound EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) NCT06401421n/a58 sites📍 Anchorage📍 Palo Alto📍 Torrance Exact Sciences Corporation · Tests: ctDNA MRD test Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring NCT04799535n/a1 site📍 Rochester Mayo Clinic · Tests: Ultrasound B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. NCT07236177EARLY Phase 11 site📍 Poitiers Poitiers University Hospital · Tests: blood plasma sample, blood sampling [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer NCT07314073Phase 21 site📍 Seoul Asan Medical Center · Tests: Fluoroestradiol (18F) Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression NCT06938373n/a1 site📍 Changsha Xiangya Hospital of Central South University Post-market Safety Study of LUMISIGHT NCT07572162n/a2 sites📍 Mobile📍 Palo Alto Lumicell, Inc. Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry NCT07616856n/a2 sites📍 Mobile📍 Palo Alto Lumicell, Inc. Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery NCT06977698n/a1 site📍 Nottingham University of Nottingham · Tests: OCT-Raman, AF-Raman Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial NCT06636370NA1 site📍 Utrecht C.H. van Gils · Tests: Contrast-enhanced mammography (CEM), Abbreviated MRI (AB-MRI) CfDNA in Hereditary And High-risk Malignancies 2 NCT06726642n/a8 sites📍 Vancouver📍 St. John's📍 Halifax University Health Network, Toronto · Tests: Cell-free DNA analysis fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases NCT06328465NA1 site📍 Milan European Institute of Oncology · Tests: Diffusion whole body MRI Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy NCT06104371n/a1 site📍 Gothenburg Vastra Gotaland Region · Tests: Magtrace Characterization of Extracellular Vesicles in Breast Cancer Patients NCT05798338n/a1 site📍 Pavia Istituti Clinici Scientifici Maugeri SpA · Tests: Blood sample Clinical Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult Women NCT07580105n/a1 site📍 Elche Kenko Imalytics S.L. · Tests: Kenko Breast AI+ A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients NCT06934239Phase 46 sites📍 Los Angeles📍 San Diego📍 Miami Jonsson Comprehensive Cancer Center · Tests: Artificial intelligence (AI) decision-support tool Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence NCT07131735n/a2 sites📍 Santiago📍 Santiago Pontificia Universidad Catolica de Chile A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection NCT06291896NA10 sites📍 Genova📍 Foligno📍 Trieste Umbria Bioengineering Technologies · Tests: MammoWave Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients NCT07524829NA1 site📍 Asti Azienda Sanitaria Locale di Asti · Tests: Structured Telenursing Follow-up, Standard Nursing Care Active Surveillance in Older Women With ER+ Breast Cancer NCT07262138n/a1 site📍 Pittsburgh University of Pittsburgh · Tests: Active Surveillance Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer NCT07146295NA7 sites📍 Alkmaar📍 Hengelo📍 Hoofddorp Isabelle Henskens · Tests: Technetium (99mTc), Indocyanine Green, Sentinel lymph node biopsy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy